Plain-English translation of NCT06512974 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether NeuroTrainer, a virtual reality-based cognitive training program, can help students with attention-related difficulties improve their ability to focus and manage their attention. The program combines game-like tasks with physical activity, designed to adapt to each student's performance level. Researchers want to see if this treatment helps students think more clearly, control their attention better, and perform better in school.
Many students struggle with attention difficulties, and current classroom-based interventions may not be enough to help them improve their focus and executive function skills. This trial is exploring whether an engaging, personalized virtual reality program could offer a new way to strengthen these important thinking skills.
You likely qualify if…
You likely don't qualify if…
If you're in the NeuroTrainer group, you would attend about 30-minute sessions three times per week for 12 weeks, where you would play virtual reality games that combine physical activity with cognitive challenges. These games adapt to your performance level to keep you engaged and challenged. If you're in the comparison group, you would continue with your regular classroom activities and typical academic support. Throughout the study, researchers will assess how your attention and academic performance change.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States
Sponsor
NeuroTrainer
Collaborators
National Institute of Mental Health (NIMH), University of California, Davis
Enrollment target
~155 participants
Started
September 2024
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
11 Years – 17 Years
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jeff Nyquist, Ph.D.
NeuroTrainer
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.